MAX-001(Maxona Pharmaceuticals)

N/A

Report date: 2025/03/13 11:08:20
NME

Base Information

Drug NameMAX-001(Maxona Pharmaceuticals)
Drug Alias NameMAX-001MAX-001(Maxona Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin reuptake inhibitorsDopamine reuptake inhibitorsNorepinephrine reuptake inhibitors
TargetsSerotonin transporterDopamine transporterNorepinephrine transporter
Therapy Area/IndicationsChronic PainAcute Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMaxona Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesMaxona Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsChronic PainAcute Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A